SAN FRANCISCO, June 5, 2025 /PRNewswire/ -- A securities class action lawsuit styled Cockrell v. UroGen Pharma Ltd. et al., No. 3:25-cv-06088 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired UroGen securities between July 27, 2023 and May 15,...
Read More Details
Finally We wish PressBee provided you with enough information of ( UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA's Briefing Document and Subsequent ODAC Vote Against UGN-102- Hagens Berman )
Also on site :
- Iconic ‘80s Actor, 76, Is Unrecognizable Nearly 35 Years After 'Dallas’
- Trump announces new round of US-China trade talks
- 'Days of Our Lives' Star, 53, Makes Plea to Fans Ahead of John Black's Funeral